Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets (1mg+500mg)

Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets (1mg+500mg) Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets IP (1mg+500mg)

 QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets IP (1mg+500mg)
  Each uncoated tablet contains:
  Glimepiride IP……………………………………….1mg
  Metformin Hydrochloride IP…………..500mg
  (In Prolonged release form)
  Excipients………………………………………q.s
  Colour: Yellow Oxide of Iron

THERAPEUTIC INDICATIONS:

Glimepiride + Metformin is a combination of two medicines: Glimepiride and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise.

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed. 

 SCHEDULE G PRESCRIPTION DRUG-CAUTION: It is dangerous to take the prescription except under medical supervision.

SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a registered medical practitioner only. 

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.

Introduction to Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets (1mg+500mg)

Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets (1mg+500mg) are a combination oral antidiabetic therapy prescribed globally for Type 2 diabetes mellitus management. This formulation combines Glimepiride (1mg), which stimulates pancreatic insulin secretion, with Metformin (500mg), which lowers hepatic glucose production and enhances insulin sensitivity in peripheral tissues.

The increasing prevalence of Type 2 diabetes worldwide has led to a surge in demand for combination therapies that provide better glycemic control and convenience for patients. Prolonged-release tablets are particularly valuable as they offer sustained blood sugar regulation, reduced dosing frequency, and improved patient adherence.

Taj Pharma, as a trusted Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets (1mg+500mg) manufacturer in India, meets global market demands with premium quality, affordable pricing, and regulatory-compliant exports.

In-Depth Details for Importers, Exporters, and Buyers

Regulatory Documentation Provided

Taj Pharma ensures seamless global trade by supplying comprehensive regulatory documentation, including:

• WHO-GMP certification

• EU-GMP approval

• Certificate of Pharmaceutical Product (COPP)

• CTD Dossiers for regulatory submission

• Free Sale Certificates

• Batch-wise Certificate of Analysis (COA)

This complete package ensures smooth product registration, customs clearance, and import approval in international markets.

Custom Packaging & Labeling

To meet diverse export requirements, Taj Pharma offers:

• Blister packs, strip packs, or bottles

• Customizable packaging with client branding

• Multilingual labeling for global compliance

• Tamper-evident, export-ready packaging

Shelf-Life, Storage & Dosage Form

• Shelf-life: 24–36 months

• Dosage Form: Prolonged-release tablets for once or twice daily administration

• Storage: Store in a cool, dry place, away from sunlight and moisture

Export Certifications

Taj Pharma adheres to global standards to ensure safe and reliable exports:

• WHO-GMP certified manufacturing units

• EU-GMP approved facilities

• ISO certification for quality management

• COPP for international trade compliance

• CTD dossiers for regulatory approvals in multiple countries

Target Countries & Export Markets

Taj Pharma exports Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets (1mg+500mg) to regions including:

• Asia: Sri Lanka, Bangladesh, Myanmar, Philippines

• Africa: Nigeria, Kenya, Ghana, South Africa

• Middle East: UAE, Saudi Arabia, Qatar, Oman

• Latin America: Peru, Chile, Bolivia, Guatemala

• CIS & Eastern Europe: Ukraine, Kazakhstan, Georgia

This global reach demonstrates Taj Pharma’s ability to provide consistent and timely supply for international buyers.

Why Taj Pharma is the Most Trusted Manufacturer, Supplier, and Exporter

1. State-of-the-Art Manufacturing

Taj Pharma’s WHO-GMP and EU-GMP certified facilities in Vapi, Gujarat, India, feature advanced technology, automated production lines, and stringent quality control protocols. Every batch of Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets undergoes thorough testing for purity, potency, and stability.

2. Affordable Pricing with Quality Assurance

Taj Pharma combines cost-effective production methods with rigorous quality control standards, offering global buyers premium medications at competitive prices, making it suitable for hospitals, government tenders, and distribution networks.

3. Global Presence & Supply Chain Support

Taj Pharma’s robust logistics network guarantees timely delivery across 70+ countries. Advanced inventory management ensures the product maintains stability during transit, providing reliable supply to international clients.

4. Top 20 Countries Exporting

1. Nigeria

2. Kenya

3. Ghana

4. South Africa

5. Philippines

6. Vietnam

7. Sri Lanka

8. Myanmar

9. UAE

10. Saudi Arabia

11. Oman

12. Qatar

13. Ukraine

14. Kazakhstan

15. Bolivia

16. Peru

17. Chile

18. Guatemala

19. Bangladesh

20. Nepal

This extensive global footprint confirms Taj Pharma’s position as a leading Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets (1mg+500mg) exporter from India.

Technical Product Specification Table

For businesses seeking premium Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets (1mg+500mg) manufacturer in India, Taj Pharma provides:

• WHO-GMP certified medications

• Customizable packaging and labeling

• Affordable bulk pricing

• Reliable international logistics support

📩 Contact Taj Pharma today to secure your partnership:
Email: info@tajpharma.com
Website: www.tajpharma.com

Top 20 FAQs  

Q1. What is Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets (1mg+500mg) used for?
A: It is prescribed for managing Type 2 diabetes by controlling blood sugar levels.

Q2. Who is the leading manufacturer in India?
A: Taj Pharma is the most trusted manufacturer and exporter.

Q3. How does this combination medicine work?
A: Glimepiride stimulates insulin secretion, while Metformin lowers liver glucose production and improves insulin sensitivity.

Q4. Can it cause hypoglycemia?
A: Yes, particularly when used with other antidiabetic medicines, alcohol, or skipped meals.

Q5. What is the shelf life?
A: 24–36 months under recommended storage conditions.

Q6. Are WHO-GMP and EU-GMP certifications available?
A: Yes, all batches are manufactured under WHO-GMP and EU-GMP standards.

Q7. Can it be used as monotherapy?
A: No, it is indicated as combination therapy for better glycemic control.

Q8. How should it be stored?
A: Store in a cool, dry place away from sunlight and moisture.

Q9. What packaging options are available?
A: Blister packs, strip packs, and bottles with export-ready labeling.

Q10. Is it suitable for international export?
A: Yes, Taj Pharma exports to over 70 countries.

Q11. Can it be supplied for government tenders?
A: Yes, it is compliant with global tender requirements.

Q12. Can distributors opt for private labeling?
A: Yes, custom branding and labeling are available for PCD franchise partners.

Q13. Are COA and stability certificates provided?
A: Yes, every batch comes with a Certificate of Analysis and stability data.

Q14. Is it safe for long-term use?
A: Yes, with regular blood sugar monitoring under medical supervision.

Q15. Can it be exported to Africa?
A: Yes, countries like Nigeria, Kenya, Ghana, and South Africa are supplied.

Q16. Is it available for PCD franchise?
A: Yes, Taj Pharma provides franchise opportunities across India.

Q17. What are common side effects?
A: Hypoglycemia, gastrointestinal discomfort, nausea, headache, and mild rash.

Q18. How does prolonged-release benefit patients?
A: It provides sustained blood sugar control, reducing dosing frequency.

Q19. How to place bulk orders?
A: Contact Taj Pharma’s export team via email or website for quotations.

Q20. Does Taj Pharma provide technical support to buyers?
A: Yes, technical and regulatory support is available for all international clients.